Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21419988 | 0.86 | CYP4F2 (0.30) | — | |
| SCHEMBL22855964 | 0.86 | PRKCA (0.33) | PRKCAPOLBGAANPSR1 | |
| SCHEMBL17828577 | 0.79 | PRKCA (0.50) | PRKCAPOLBGAANPSR1 | |
| SCHEMBL26040609 | 0.78 | — | — | |
| SCHEMBL19865688 | 0.76 | POLB (0.36) | PRKCAPOLBGAANPSR1 | |
| SCHEMBL17874894 | 0.75 | MAPK1 (0.35) | — | |
| SCHEMBL13073713 | 0.75 | POLB (0.40) | PRKCAPOLBGAANPSR1 | |
| SCHEMBL24901922 | 0.75 | CYP1A2 (0.35) | — | |
| SCHEMBL20289859 | 0.72 | PRKCA (0.34) | PRKCAPOLBGAANPSR1 | |
| SCHEMBL22697443 | 0.71 | POLB (0.35) | PRKCAPOLBGAANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200405881-A1 | CELL BASED METHODS AND COMPOSITIONS FOR THERAPEUTIC AGENT DELIVERY AND TREATMENTS USING SAME | UNIVERSITY OF WASHINGTON (US) | 2020-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200405881-A1 | CELL BASED METHODS AND COMPOSITIONS FOR THERAPEUTIC AGENT DELIVERY AND TREATMENTS USING SAME | CXCL12, CD47, CD44 | PRKCA 1315/4885POLB 2877/4885GAA 1457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.